These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8517711)

  • 1. Penetration of cefprozil into tonsillar and adenoidal tissues.
    Shyu WC; Reilly J; Campbell DA; Wilber RB; Barbhaiya RH
    Antimicrob Agents Chemother; 1993 May; 37(5):1180-3. PubMed ID: 8517711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of cefprozil into middle ear fluid of patients with otitis media.
    Shyu WC; Haddad J; Reilly J; Khan WN; Campbell DA; Tsai Y; Barbhaiya RH
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2210-2. PubMed ID: 7811050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excretion of cefprozil into human breast milk.
    Shyu WC; Shah VR; Campbell DA; Venitz J; Jaganathan V; Pittman KA; Wilber RB; Barbhaiya RH
    Antimicrob Agents Chemother; 1992 May; 36(5):938-41. PubMed ID: 1510416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered dipeptidyl peptidase IV and prolyl endopeptidase activities in chronic tonsillitis, tonsillar hyperplasia and adenoid hyperplasia.
    Larrinaga G; Pérez I; Sanz B; Zarrazquin I; Casis L; Anta JA; Martínez A; Santaolalla F
    Int J Pediatr Otorhinolaryngol; 2011 Mar; 75(3):347-50. PubMed ID: 21185091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral absolute bioavailability and intravenous dose-proportionality of cefprozil in humans.
    Shyu WC; Shah VR; Campbell DA; Wilber RB; Pittman KA; Barbhaiya RH
    J Clin Pharmacol; 1992 Sep; 32(9):798-803. PubMed ID: 1430299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of soluble aminopeptidase A and dipeptidyl peptidase IV and membrane-bound aminopeptidase B and pyroglutamyl peptidase I in adenoid hyperplasia, tonsillar hyperplasia and chronic tonsillitis.
    Larrinaga G; Perez I; Sanz B; Irazusta A; Zarrazquin I; Sanchez CE; Rey AS; Zabala A; Santaolalla F
    Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1399-403. PubMed ID: 21937126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of cefpodoxime in plasma, adenoid, and tonsillar tissue after repeated administrations of cefpodoxime proxetil in children.
    Bairamis TN; Nikolopoulos TP; Kafetzis DA; Begue P; Lenfant B; Kandiloros DC; Apostolopoulos NJ
    J Antimicrob Chemother; 1996 Apr; 37(4):821-4. PubMed ID: 8722549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The penetration of erythromycin into Waldeyer's ring--tonsil and adenoid tissue.
    Sundberg L; Edén T; Ernstson S
    Infection; 1982; 10 Suppl 2():S105-7. PubMed ID: 6980840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment.
    Shyu WC; Pittman KA; Wilber RB; Matzke GR; Barbhaiya RH
    J Clin Pharmacol; 1991 Apr; 31(4):362-71. PubMed ID: 2037710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefprozil in infants and children.
    Sáez-Llorens X; Shyu WC; Shelton S; Kumiesz H; Nelson J
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2152-5. PubMed ID: 2073105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the cost benefit ratio of sending adeno-tonsillar tissues for histology: does adenoid/tonsillar tissue in children undergo malignant transformation?
    Chinawa JM; Chinawa AT; Akpe J; Kelvin-Iloafu L; Onukwuli V
    Pan Afr Med J; 2019; 32():193. PubMed ID: 31312305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differences in the expression of fractalkine and its receptor in conditions of tonsillar hypertrophy and chronic tonsillitis.
    Koclu Hetemoglu E; Turkoglu Babakurban S; Terzi YK; Sahin FI; Erbek SS
    Auris Nasus Larynx; 2019 Aug; 46(4):565-569. PubMed ID: 30554983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antacid on the bioavailability of cefprozil.
    Shyu WC; Wilber RB; Pittman KA; Barbhaiya RH
    Antimicrob Agents Chemother; 1992 May; 36(5):962-5. PubMed ID: 1510420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of azithromycin in tonsilar and/or adenoid tissue from paediatric patients.
    Vaudaux BP; Cherpillod J; Dayer P
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():45-51. PubMed ID: 8818845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of adenoid weight to tonsillar weight.
    Stearns M
    J Laryngol Otol; 1983 Jun; 97(6):519-21. PubMed ID: 6864090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
    Barbhaiya RH; Shukla UA; Gleason CR; Shyu WC; Wilber RB; Pittman KA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1204-9. PubMed ID: 2393282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between plasma and tonsillar levels of cefroxadine.
    Fraschini F; Scaglione F; Vago F; Bichisao E; Borghi C; Montanari M
    Chemotherapy; 1988; 34(1):8-12. PubMed ID: 3349862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of resection of adenoids and/or tonsil on the immune indexes in children with obstructive sleep apnea hypopnea syndrome].
    Hao X; Wang JZ; Qu H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Nov; 54(11):830-836. PubMed ID: 31795544
    [No Abstract]   [Full Text] [Related]  

  • 19. [Basophils from palatine tonsils and adenoids in recurrent acute adenoid tonsillitis and adenoid tonsillar hypertrophy in children].
    López González MA; Alonso Rosa D; Mata Maderuelo F; Delgado Moreno F
    Acta Otorrinolaringol Esp; 2001 May; 52(4):364-6. PubMed ID: 11526635
    [No Abstract]   [Full Text] [Related]  

  • 20. Redefining the management of pediatric tonsillopharyngitis with cefprozil.
    Jerath N; Shetty G
    Indian J Pediatr; 2007 Dec; 74(12):1105-8. PubMed ID: 18174646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.